logo
Plus   Neg
Share
Email

Innoviva, GSK: EU Approves Label Update To Relvar Ellipta In Asthma Patients

Innoviva, Inc. (INVA) and GlaxoSmithKline plc (GSK,GSK.L) announced Thursday that the European Commission has approved a label update to Relvar Ellipta in patients with asthma.

The label update is for the use of once-daily Relvar Ellipta (fluticasone furoate/vilanterol, FF/VI), an inhaled corticosteroid (ICS) / long-acting ß2-agonist (LABA) combination, in patients whose asthma is already adequately controlled on both an inhaled corticosteroid and long-acting ß2-agonist.

The updated marketing authorisation by the European Commission will be reflected in the label for Relvar Ellipta for countries in the European Union.

The company said the Type II variation regulatory approval has been supported by data from a non-inferiority lung function study, which demonstrated that patients with adequately controlled asthma were able to switch to the once-daily FF/VI 100/25, from the twice-daily Seretide Accuhaler (fluticasone propionate /salmeterol, FP/SAL) 250/50, without compromising their lung function. No new safety signals were identified and the adverse event data were consistent with the known safety profile for FF/VI established in patients with asthma.

Jonathan Sweeting, SVP and Head of Global Respiratory Franchise GSK, said: "Patients with asthma can continue to experience symptoms despite being adequately controlled and these symptoms can impact their lives. This label update gives doctors the option of switching appropriate patients from their current ICS/LABA to once-daily Relvar Ellipta."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
UK economic growth slowed in the three months to October, mainly due to a fall in car sales and stagnation in manufacturing, as the uncertainty surrounding the country's decision to leave the European Union, dubbed Brexit, intensified. Gross domestic product grew 0.4 percent in the three months to October, which was slower than the 0.6 percent expansion in the September quarter. Germany's merchandise exports grew more-than-expected in October and at the fastest pace in five months, preliminary figures from Destatis showed on Monday. Exports increased a calendar ad seasonally adjusted 0.7 percent from September, when they declined 0.4 percent. Economists had forecast a 0.4 percent gain for October. Japanese prosecutors have indicted Japanese automaker Nissan Motor Co. Ltd. and its former chairman Carlos Ghosn on allegations of financial misconduct. Former Nissan director Greg Kelly was also indicted. Nissan said Monday that its Ghosn and Kelly were indicted for violating the Japan Financial Instruments and Exchange Act, namely making false disclosures in annual securities reports.
Follow RTT